GMEDGlobus Medical, Inc.
Price
+34%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality mixed, no red flags, undemanding price, growing in the filings, the market undecided.
Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, “Globus,” the “Company,” “we,” “us” or “our”), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Globus Medical, Inc. (GMED) reported revenue of $790M in Q2 2026 (quarter ended Jun 30, 2026), up 5.9% from the same quarter a year earlier. That came with a gross margin of 69% and net income of $152M (19% of revenue). For the full year FY2025, revenue was $2.94B (+17% year on year) and net income $538M. Its largest product in Q2 2026 was Musculoskeletal Solutions at $764M, 97% of the disclosed total, well ahead of Enabling Technologies at 3.3%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Globus Medical Reports Second Quarter 2026 Results.Earnings release · press release
- Jun 4, 2026On June 3, 2026, Globus Medical, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) at which the Company’s stockholders approved an amendment (the “2021 Equity Incentive Plan Amendment”) to the Globus Medical, Inc. 2021 Equity Incentive Plan (the “Plan”) to increase the number of …Director or officer change · Form 8-K
- May 7, 2026Globus Medical Reports First Quarter 2026 Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $789.6MThe company’s own SEC segment disclosure.
- Musculoskeletal Solutions$763.5M97%
- Enabling Technologies$26.1M3%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.